BNP Paribas Financial Markets’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.8M Buy
62,008
+19,852
+47% +$9.89M 0.02% 824
2025
Q4
$20.5M Sell
42,156
-27,941
-40% -$13M 0.01% 1157
2025
Q3
$29.4M Buy
70,097
+25,202
+56% +$8.48M 0.02% 893
2025
Q2
$12.9M Buy
44,895
+6,434
+17% +$1.92M 0.01% 1275
2025
Q1
$11.9M Buy
38,461
+2,347
+6% +$804K 0.01% 1312
2024
Q4
$12.7M Buy
36,114
+1,922
+6% +$706K 0.01% 1228
2024
Q3
$12.3M Sell
34,192
-21,416
-39% -$7.23M 0.01% 1082
2024
Q2
$17.7M Buy
55,608
+19,801
+55% +$5.24M 0.02% 827
2024
Q1
$8.23M Sell
35,807
-19,674
-35% -$4.44M 0.01% 1166
2023
Q4
$12.2M Buy
55,481
+26,325
+90% +$6.07M 0.02% 934
2023
Q3
$6.59M Sell
29,156
-1,860
-6% -$428K 0.01% 1094
2023
Q2
$6.85M Sell
31,016
-2,238
-7% -$496K 0.01% 1075
2023
Q1
$7.45M Sell
33,254
-19,522
-37% -$4.81M 0.02% 1043
2022
Q4
$14.7M Buy
52,776
+35,510
+206% +$8.96M 0.04% 790
2022
Q3
$3.62M Buy
17,266
+1,116
+7% +$249K 0.01% 1540
2022
Q2
$3.81M Sell
16,150
-21
-0.1% -$4.27K 0.01% 1372
2022
Q1
$2.9M Sell
16,171
-19,933
-55% -$3.8M 0.01% 1596
2021
Q4
$7.8M Buy
36,104
+6,370
+21% +$1.25M 0.02% 1103
2021
Q3
$5.49M Sell
29,734
-17,528
-37% -$3.45M 0.01% 1247
2021
Q2
$8.48M Buy
47,262
+32,568
+222% +$6.2M 0.02% 1020
2021
Q1
$2.46M Sell
14,694
-67,582
-82% -$11.3M 0.01% 1547
2020
Q4
$12.5M Buy
82,276
+71,406
+657% +$9.37M 0.05% 696
2020
Q3
$1.1M Sell
10,870
-56,020
-84% -$6.15M ﹤0.01% 1764
2020
Q2
$8.09M Buy
66,890
+37,471
+127% +$4.22M 0.02% 803
2020
Q1
$2.79M Sell
29,419
-45,557
-61% -$4.33M 0.01% 1293
2019
Q4
$6.6M Buy
74,976
+58,725
+361% +$5.17M 0.03% 1049
2019
Q3
$1.3M Sell
16,251
-13,579
-46% -$1.09M ﹤0.01% 1724
2019
Q2
$2.33M Sell
29,830
-27,793
-48% -$2.6M 0.01% 1384
2019
Q1
$6.76M Buy
57,623
+31,914
+124% +$3.72M 0.02% 870
2018
Q4
$2.8M Sell
25,709
-526
-2% -$61K 0.01% 1168
2018
Q3
$3.35M Sell
26,235
-52,848
-67% -$6.54M 0.01% 1297
2018
Q2
$8.95M Buy
79,083
+62,539
+378% +$6.87M 0.02% 841
2018
Q1
$1.86M Sell
16,544
-46,609
-74% -$5.92M 0.01% 1421
2017
Q4
$9.34M Buy
63,153
+24,346
+63% +$3.09M 0.04% 750
2017
Q3
$4.55M Sell
38,807
-324,661
-89% -$41.5M 0.01% 829
2017
Q2
$47.2M Sell
363,468
-1,736
-0.5% -$217K 0.15% 132
2017
Q1
$49.4M Buy
365,204
+215,017
+143% +$32.6M 0.14% 158
2016
Q4
$21.5M Buy
150,187
+140,225
+1,408% +$17.9M 0.11% 176
2016
Q3
$1.18M Sell
9,962
-77,715
-89% -$9.34M ﹤0.01% 875
2016
Q2
$9.29M Sell
87,677
-30,517
-26% -$3.4M 0.04% 310
2016
Q1
$13.2M Sell
118,194
-64,590
-35% -$8.17M 0.06% 288
2015
Q4
$28.6M Buy
182,784
+89,722
+96% +$13.1M 0.07% 226
2015
Q3
$12.2M Buy
93,062
+13,711
+17% +$2.2M 0.03% 374
2015
Q2
$13.8M Buy
79,351
+21,981
+38% +$3.95M 0.04% 269
2015
Q1
$9.89M Buy
57,370
+6,150
+12% +$938K 0.03% 404
2014
Q4
$6.63M Buy
51,220
+2,233
+5% +$288K 0.02% 552
2014
Q3
$6.3M Sell
48,987
-38,218
-44% -$3.94M 0.01% 655
2014
Q2
$7.72M Sell
87,205
-12,489,447
-99% -$1.2B 0.01% 509
2014
Q1
$2.65B Buy
12,576,652
+12,508,648
+18,394% +$1.28B 2.09% 9
2013
Q4
$2.97B Sell
68,004
-12,544,537
-99% -$1.13B 2.19% 5
2013
Q3
$2.13B Sell
12,612,541
-43,242
-0.3% -$3.16M 1.57% 14
2013
Q2
$1.82B Buy
+12,655,783
New +$815M 1.31% 26

Other funds holding UTHR